Condition: Immune Thrombocytopenia · Sponsor: Peking University People's Hospital
This is a prospective, randomized, open-label, multicenter clinical trial study to compare the efficacy and safety of prednisone plus IVIg to prednisone monotherapy in the treatment of immune thrombocytopenia (ITP) in pregnancy.
This description comes directly from the study's public registry record.
Xiaohui Zhang, Professor · +8613522338836 · zhangxh100@sina.com
Haixia Fu, MD · 13581830157 · fuhaixia_210@163.com
Always discuss trial participation with your own doctor first.
| Peking University Insititute of Hematology, Peking University People's Hospital | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06577909